Brazil's Federal Revenue Agency Seizes 1.37 Million Smuggled E-cigarettes

Regulations by 2FIRSTS.ai

Apr.29.2024

Brazil's Federal Revenue Agency Seizes 1.37 Million Smuggled E-cigarettes

Brazilian Federal Revenue agency discovered a surge in e-cigarette smuggling, with 1,367,719 seized in 2023, totaling over $11.96 million.

According to the Brazilian media Metropoles, on April 29, 2023, the Brazilian Federal Revenue Service seized a total of 1,367,719 smuggled e-cigarettes, representing a 24.9% increase compared to the previous year. The estimated total value of these seized e-cigarettes is approximately 61.2 million Brazilian reais (11.96 million US dollars).

In 2021, the agency seized a total of 450,704 units, a 1397% increase compared to the previous year. The seizure quantity in 2022 increased by 143% compared to the previous year, reaching 1,094,622 units. From 2019 to 2023, the agency has seized a total value of smuggled e-cigarettes worth 134.3 million Brazilian Reais (26.24 million US dollars).

Among them, the state of Parana had the highest seizure of e-cigarettes in 2023, confiscating 618,200 units. Following closely behind were South Mato Grosso (363,900), Sao Paulo (135,700), Santa Catarina (133,300), and Goias (25,100).

References:

[1] Apreensão de cigarros eletrônicos sobe 25% e chega a 1,3 milhão

Also Read:

[1] Brazil Bans E-cigarette Devices in Effort to Protect Public Health

[2] Brazilian Senator Soraya Thronicke Opposes Anvisa's E-Cigarette Ban

[3] Brazil to Review Vape Sales Ban Again

[4] Brazilian Health Authority Delays Debate on E-cigarette Regulations to the 19th

[5] Brazil Considers Ban on E-cigarettes: Anvisa Decision Coming Soon

[6] BAT CEO Urges Anvisa to Advance E-Cigarette Regulation in Brazil

[7] Brazil Health Authority to Reevaluate Ban on E-Cigarettes

#Law enforcement #Open system e-cigarettes #Disposable e-cigarettes #Regulation #South America #Brazil

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most

In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.

Oct.21

Altria Director George Muñoz to Retire After 2026 Shareholder Meeting;

Altria director George Muñoz plans to retire post-2026 annual meeting, not seeking re-election. Annual meeting expected on May 14.

Oct.15 by 2FIRSTS.ai

South Korea’s Parliament Reconsiders Bill to Regulate Synthetic Nicotine as Tobacco

South Korea’s National Assembly is once again reviewing a bill to classify synthetic nicotine as a tobacco product under the Tobacco Business Act. The proposal aims to close regulatory loopholes that allow untaxed, unregulated nicotine liquids — often used by minors — to circulate freely. Lawmakers expect the bill to pass during the current session amid growing public and civic pressure.

Nov.26 by 2FIRSTS.ai

Philip Morris and R.J. Reynolds Face Trial Over Woman’s Lung Cancer Death in Massachusetts

According to Law360, the family of Maria Petruzziello has taken Philip Morris and R.J. Reynolds to trial in Massachusetts, alleging the companies are responsible for her 2019 lung cancer death after decades of smoking. Plaintiffs argue her experience mirrors many smokers, while the defense points to her years-long cessation and personal choice.